Skip to main content
Top
Published in: Journal of Neurology 7/2016

01-07-2016 | Original Communication

Independent impact of infections on the course and outcome of status epilepticus: a 10-year cohort study

Authors: Saskia Semmlack, Sarah Tschudin-Sutter, Andreas F. Widmer, Martina Valença, Stephan Rüegg, Stephan Marsch, Raoul Sutter

Published in: Journal of Neurology | Issue 7/2016

Login to get access

Abstract

Infections are frequent in patients with status epilepticus (SE). It remains unclear if infections merely reflect severity of the underlying illness or if they independently predict unfavourable course and outcome. We sought to determine if infections diagnosed within 48 h from SE onset are independent predictors of poor course and outcome and if their effect is modified by clinical characteristics. From 2005 to 2014, pertinent clinical data, microbiology, death, return to functional baseline, and unfavourable outcome in survivors were assessed in SE patients treated in the intensive care units (ICU) of an academic medical care center. Among 352 consecutive patients, 81 (23 %) were diagnosed with infections at SE onset. In-hospital mortality was higher in patients with infections (26 %) compared to 10 % in patients without infections (p < 0.001). Infections at SE onset increased the odds ratios (OR) for prolonged ICU (OR = 4.1, 95 %CI 1.87–6.74) and hospital stay (OR = 5.4, 95 %CI 1.24–9.63), refractory SE (OR = 3.1, 95 %CI 1.79–5.34), prolonged mechanical ventilation (OR = 3.8, 95 %CI 2.15–6.79), no return to functional baseline (OR = 2.1, 95 %CI 1.10–4.02), unfavourable outcome in survivors (OR = 2.0, 95 %CI 1.02–3.81), and death (OR = 2.5, 95 %CI 1.28–4.99). All associations were independent of confounders and without significant effect modification by age, level of consciousness, types and severity of SE, and etiologies. In addition, the number of infections increased the probability of unfavourable course and outcome. Infections at SE onset are frequent and associated with prolonged medical care, treatment refractory SE, higher morbidity and mortality independently of potential confounders calling for the evaluation of treatment strategies.
Literature
1.
go back to reference Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM (2012) Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 17:3–23CrossRefPubMed Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM (2012) Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 17:3–23CrossRefPubMed
2.
go back to reference Sutter R, Kaplan PW, Rüegg S (2013) Outcome predictors for status epilepticus—what really counts. Nat Rev Neurol 9:525–534CrossRefPubMed Sutter R, Kaplan PW, Rüegg S (2013) Outcome predictors for status epilepticus—what really counts. Nat Rev Neurol 9:525–534CrossRefPubMed
3.
go back to reference Sutter R, Rüegg S (2013) Predicting outcome in adults with status epilepticus. Z Epileptol 26:79–84CrossRef Sutter R, Rüegg S (2013) Predicting outcome in adults with status epilepticus. Z Epileptol 26:79–84CrossRef
4.
go back to reference Sutter R, Tschudin-Sutter S, Grize L, Fuhr P, Bonten MJ, Widmer AF, Marsch S, Ruegg S (2012) Associations between infections and clinical outcome parameters in status epilepticus: a retrospective 5-year cohort study. Epilepsia 53:1489–1497CrossRefPubMed Sutter R, Tschudin-Sutter S, Grize L, Fuhr P, Bonten MJ, Widmer AF, Marsch S, Ruegg S (2012) Associations between infections and clinical outcome parameters in status epilepticus: a retrospective 5-year cohort study. Epilepsia 53:1489–1497CrossRefPubMed
5.
go back to reference Zelano J, Moller F, Dobesberger J, Trinka E, Kumlien E (2014) Infections in status epilepticus: a retrospective 5-year cohort study. Seizure 23:603–606CrossRefPubMed Zelano J, Moller F, Dobesberger J, Trinka E, Kumlien E (2014) Infections in status epilepticus: a retrospective 5-year cohort study. Seizure 23:603–606CrossRefPubMed
6.
go back to reference Ala-Kokko TI, Säynäjäkangas P, Laurila P, Ohtonen P, Laurila JJ, Syrjälä H (2006) Incidence of infections in patients with status epilepticus requiring intensive care and effect on resource utilization. Anaesth Intensive Care 34:639–644PubMed Ala-Kokko TI, Säynäjäkangas P, Laurila P, Ohtonen P, Laurila JJ, Syrjälä H (2006) Incidence of infections in patients with status epilepticus requiring intensive care and effect on resource utilization. Anaesth Intensive Care 34:639–644PubMed
7.
go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S (2007) The Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457CrossRef von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S (2007) The Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457CrossRef
8.
go back to reference Commission on Epidemiology and Prognosis of the International League Against Epilepsy (1993) Guidelines for epidemiologic studies on epilepsy. Epilepsia 34:592–596CrossRef Commission on Epidemiology and Prognosis of the International League Against Epilepsy (1993) Guidelines for epidemiologic studies on epilepsy. Epilepsia 34:592–596CrossRef
9.
go back to reference Sutter R, Marsch S, Fuhr P, Kaplan PW, Rüegg S (2014) Anesthetic drugs in status epilepticus—risk or rescue? A six-year cohort study. Neurology 82:656–664CrossRefPubMedPubMedCentral Sutter R, Marsch S, Fuhr P, Kaplan PW, Rüegg S (2014) Anesthetic drugs in status epilepticus—risk or rescue? A six-year cohort study. Neurology 82:656–664CrossRefPubMedPubMedCentral
10.
go back to reference Rossetti AO, Logroscino G, Bromfield EB (2006) A clinical score for prognosis of status epilepticus in adults. Neurology 66:1736–1738CrossRefPubMed Rossetti AO, Logroscino G, Bromfield EB (2006) A clinical score for prognosis of status epilepticus in adults. Neurology 66:1736–1738CrossRefPubMed
11.
go back to reference Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB (2008) Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol 255:1561–1566CrossRefPubMed Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB (2008) Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol 255:1561–1566CrossRefPubMed
12.
go back to reference Sutter R, Kaplan PW, Rüegg S (2013) Independent external validation of the Status Epilepticus Severity Score. Crit Care Med 41:e475–479CrossRefPubMed Sutter R, Kaplan PW, Rüegg S (2013) Independent external validation of the Status Epilepticus Severity Score. Crit Care Med 41:e475–479CrossRefPubMed
13.
go back to reference Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, Shorvon S, Lowenstein DH (2015) A definition and classification of status epilepticus–Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 56:1515–1523CrossRefPubMed Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, Shorvon S, Lowenstein DH (2015) A definition and classification of status epilepticus–Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 56:1515–1523CrossRefPubMed
14.
go back to reference Kroeger D, Amzica F (2007) Hypersensitivity of the anesthesia-induced comatose brain. J Neurosci 27:10597–10607CrossRefPubMed Kroeger D, Amzica F (2007) Hypersensitivity of the anesthesia-induced comatose brain. J Neurosci 27:10597–10607CrossRefPubMed
15.
go back to reference Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140CrossRefPubMed Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140CrossRefPubMed
16.
go back to reference Novy J, Logroscino G, Rossetti AO (2010) Refractory status epilepticus: a prospective observational study. Epilepsia 51:251–256CrossRefPubMed Novy J, Logroscino G, Rossetti AO (2010) Refractory status epilepticus: a prospective observational study. Epilepsia 51:251–256CrossRefPubMed
17.
go back to reference Agan K, Afsar N, Midi I, Us O, Balosso S, Aykut-Bingol C (2009) Predictors of refractoriness in a Turkish status epilepticus data bank. Epilepsy Behav 14:651–654CrossRefPubMed Agan K, Afsar N, Midi I, Us O, Balosso S, Aykut-Bingol C (2009) Predictors of refractoriness in a Turkish status epilepticus data bank. Epilepsy Behav 14:651–654CrossRefPubMed
18.
go back to reference Knake S, Rosenow F, Vescovi M, Oertel WH, Mueller HH, Wirbatz A, Katsarou N, Hamer HM (2001) Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 42:714–718CrossRefPubMed Knake S, Rosenow F, Vescovi M, Oertel WH, Mueller HH, Wirbatz A, Katsarou N, Hamer HM (2001) Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 42:714–718CrossRefPubMed
19.
go back to reference Koubeissi M, Alshekhlee A (2007) In-hospital mortality of generalized convulsive status epilepticus: a large US sample. Neurology 69:886–893CrossRefPubMed Koubeissi M, Alshekhlee A (2007) In-hospital mortality of generalized convulsive status epilepticus: a large US sample. Neurology 69:886–893CrossRefPubMed
20.
go back to reference Privitera M, Hoffman M, Moore JL, Jester D (1994) EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness. Epilepsy Res 18:155–166CrossRefPubMed Privitera M, Hoffman M, Moore JL, Jester D (1994) EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness. Epilepsy Res 18:155–166CrossRefPubMed
21.
go back to reference Sutter R, Tschudin-Sutter S, Grize L, Widmer AF, Marsch S, Ruegg S (2011) Acute phase proteins and white blood cell levels for prediction of infectious complications in status epilepticus. Crit Care 15:R274CrossRefPubMedPubMedCentral Sutter R, Tschudin-Sutter S, Grize L, Widmer AF, Marsch S, Ruegg S (2011) Acute phase proteins and white blood cell levels for prediction of infectious complications in status epilepticus. Crit Care 15:R274CrossRefPubMedPubMedCentral
22.
go back to reference Sutter R, Grize L, Fuhr P, Rüegg S, Marsch S (2013) Acute phase proteins and mortality in status epilepticus: a five-year observational cohort study. Crit Care Med 41:1526–1533CrossRefPubMed Sutter R, Grize L, Fuhr P, Rüegg S, Marsch S (2013) Acute phase proteins and mortality in status epilepticus: a five-year observational cohort study. Crit Care Med 41:1526–1533CrossRefPubMed
23.
go back to reference Sutter R, Valenca M, Tschudin-Sutter S, Ruegg S, Marsch S (2015) Procalcitonin and mortality in status epilepticus: an observational cohort study. Crit Care 19:361CrossRefPubMedPubMedCentral Sutter R, Valenca M, Tschudin-Sutter S, Ruegg S, Marsch S (2015) Procalcitonin and mortality in status epilepticus: an observational cohort study. Crit Care 19:361CrossRefPubMedPubMedCentral
24.
go back to reference Marchi N, Angelov L, Masaryk T, Fazio V, Granata T, Hernandez N, Hallene K, Diglaw T, Franic L, Najm I, Janigro D (2007) Seizure-promoting effect of blood–brain barrier disruption. Epilepsia 48:732–742CrossRefPubMedPubMedCentral Marchi N, Angelov L, Masaryk T, Fazio V, Granata T, Hernandez N, Hallene K, Diglaw T, Franic L, Najm I, Janigro D (2007) Seizure-promoting effect of blood–brain barrier disruption. Epilepsia 48:732–742CrossRefPubMedPubMedCentral
25.
go back to reference Fabene PF, Navarro Mora G, Martinello M, Rossi B, Merigo F, Ottoboni L, Bach S, Angiari S, Benati D, Chakir A, Zanetti L, Schio F, Osculati A, Marzola P, Nicolato E, Homeister JW, Xia L, Lowe JB, McEver RP, Osculati F, Sbarbati A, Butcher EC, Constantin G (2008) A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 14:1377–1383CrossRefPubMedPubMedCentral Fabene PF, Navarro Mora G, Martinello M, Rossi B, Merigo F, Ottoboni L, Bach S, Angiari S, Benati D, Chakir A, Zanetti L, Schio F, Osculati A, Marzola P, Nicolato E, Homeister JW, Xia L, Lowe JB, McEver RP, Osculati F, Sbarbati A, Butcher EC, Constantin G (2008) A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 14:1377–1383CrossRefPubMedPubMedCentral
26.
go back to reference Janigro D (2012) Are you in or out? Leukocyte, ion, and neurotransmitter permeability across the epileptic blood–brain barrier. Epilepsia 53(Suppl 1):26–34CrossRefPubMedPubMedCentral Janigro D (2012) Are you in or out? Leukocyte, ion, and neurotransmitter permeability across the epileptic blood–brain barrier. Epilepsia 53(Suppl 1):26–34CrossRefPubMedPubMedCentral
27.
go back to reference Pacifici R, Paris L, Di Carlo S, Bacosi A, Pichini S, Zuccaro P (1995) Cytokine production in blood mononuclear cells from epileptic patients. Epilepsia 36:384–387CrossRefPubMed Pacifici R, Paris L, Di Carlo S, Bacosi A, Pichini S, Zuccaro P (1995) Cytokine production in blood mononuclear cells from epileptic patients. Epilepsia 36:384–387CrossRefPubMed
28.
go back to reference Bauer S, Köller M, Cepok S, Todorova-Rudolph A, Nowak M, Nockher WA, Lorenz R, Tackenberg B, Oertel WH, Rosenow F, Henner B, Hamer HM (2008) NK and CD4+ T cell changes in blood after seizures in temporal lobe epilepsy. Exp Neurol 211:370–377CrossRefPubMed Bauer S, Köller M, Cepok S, Todorova-Rudolph A, Nowak M, Nockher WA, Lorenz R, Tackenberg B, Oertel WH, Rosenow F, Henner B, Hamer HM (2008) NK and CD4+ T cell changes in blood after seizures in temporal lobe epilepsy. Exp Neurol 211:370–377CrossRefPubMed
29.
go back to reference Vezzani A, Viviani B (2015) Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology 96:70–82CrossRefPubMed Vezzani A, Viviani B (2015) Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology 96:70–82CrossRefPubMed
30.
go back to reference Heinemann U, Kaufer D, Friedman A (2012) Blood–brain barrier dysfunction, TGFbeta signaling, and astrocyte dysfunction in epilepsy. Glia 60:1251–1257CrossRefPubMedPubMedCentral Heinemann U, Kaufer D, Friedman A (2012) Blood–brain barrier dysfunction, TGFbeta signaling, and astrocyte dysfunction in epilepsy. Glia 60:1251–1257CrossRefPubMedPubMedCentral
31.
32.
go back to reference Montgomery SL, Bowers WJ (2012) Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J Neuroimmune Pharmacol 7:42–59CrossRefPubMed Montgomery SL, Bowers WJ (2012) Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J Neuroimmune Pharmacol 7:42–59CrossRefPubMed
33.
go back to reference Vezzani A, French J, Bartfai T, Baram TZ (2011) The role of inflammation in epilepsy. Nat Rev Neurol 7:31–40CrossRefPubMed Vezzani A, French J, Bartfai T, Baram TZ (2011) The role of inflammation in epilepsy. Nat Rev Neurol 7:31–40CrossRefPubMed
34.
go back to reference Viviani B, Gardoni F, Marinovich M (2007) Cytokines and neuronal ion channels in health and disease. Int Rev Neurobiol 82:247–263CrossRefPubMed Viviani B, Gardoni F, Marinovich M (2007) Cytokines and neuronal ion channels in health and disease. Int Rev Neurobiol 82:247–263CrossRefPubMed
36.
go back to reference Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T (2011) IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 25:1281–1289CrossRefPubMed Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T (2011) IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 25:1281–1289CrossRefPubMed
37.
go back to reference Nguyen MD, Julien JP, Rivest S (2002) Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 3:216–227CrossRefPubMed Nguyen MD, Julien JP, Rivest S (2002) Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 3:216–227CrossRefPubMed
38.
go back to reference Gardoni F, Boraso M, Zianni E, Corsini E, Galli CL, Cattabeni F, Marinovich M, Di Luca M, Viviani B (2011) Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1beta and NMDA stimulation. J Neuroinflammation 8:14CrossRefPubMedPubMedCentral Gardoni F, Boraso M, Zianni E, Corsini E, Galli CL, Cattabeni F, Marinovich M, Di Luca M, Viviani B (2011) Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1beta and NMDA stimulation. J Neuroinflammation 8:14CrossRefPubMedPubMedCentral
40.
go back to reference Claassen J, Riviello JJ Jr, Silbergleit R (2015) Emergency neurological life support: status epilepticus. Neurocrit Care 23(Suppl 2):136–142CrossRef Claassen J, Riviello JJ Jr, Silbergleit R (2015) Emergency neurological life support: status epilepticus. Neurocrit Care 23(Suppl 2):136–142CrossRef
Metadata
Title
Independent impact of infections on the course and outcome of status epilepticus: a 10-year cohort study
Authors
Saskia Semmlack
Sarah Tschudin-Sutter
Andreas F. Widmer
Martina Valença
Stephan Rüegg
Stephan Marsch
Raoul Sutter
Publication date
01-07-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 7/2016
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-016-8140-1

Other articles of this Issue 7/2016

Journal of Neurology 7/2016 Go to the issue